These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
45. Renal denervation therapy for the treatment of resistant hypertension: a position statement by the Canadian Hypertension Education Program. Khan NA; Herman RJ; Quinn RR; Rabkin SW; Ravani P; Tobe SW; Feldman RD; Wijeysundera HC; Padwal RS; Can J Cardiol; 2014 Jan; 30(1):16-21. PubMed ID: 24269056 [TBL] [Abstract][Full Text] [Related]
46. Transradial renal denervation for the treatment of resistant hypertension. Dong H; Jiang X; Liang T; Zou Y; Guan T; Peng M; Song L; Zhang H; Wu H; Xu B; Yang Y; Gao R J Invasive Cardiol; 2014 Jul; 26(7):322-7. PubMed ID: 24993989 [TBL] [Abstract][Full Text] [Related]
47. Prevalence of resistant hypertension and eligibility for catheter-based renal denervation in hypertensive outpatients. Hayek SS; Abdou MH; Demoss BD; Legaspi JM; Veledar E; Deka A; Krishnan SK; Wilmot KA; Patel AD; Kumar VR; Devireddy CM Am J Hypertens; 2013 Dec; 26(12):1452-8. PubMed ID: 23934709 [TBL] [Abstract][Full Text] [Related]
48. [Renal sympathetic denervation: still to follow after Symplicity HTN-3? No]. Philipp T; Mitchell A; Philipp S Dtsch Med Wochenschr; 2014 Nov; 139(48):2467. PubMed ID: 25409408 [No Abstract] [Full Text] [Related]
49. [Renal sympathetic denervation: still to follow after Symplicity HTN-3? Yes]. Mahfoud F Dtsch Med Wochenschr; 2014 Nov; 139(48):2466. PubMed ID: 25409407 [No Abstract] [Full Text] [Related]
50. Renal denervation with a percutaneous bipolar radiofrequency balloon catheter in patients with resistant hypertension: 6-month results from the REDUCE-HTN clinical study. Sievert H; Schofer J; Ormiston J; Hoppe UC; Meredith IT; Walters DL; Azizi M; Diaz-Cartelle J; Cohen-Mazor M EuroIntervention; 2015 Feb; 10(10):1213-20. PubMed ID: 25452197 [TBL] [Abstract][Full Text] [Related]
51. [Surgery of abdominal aorta with horseshoe kidney]. Lotina SL; Davidović LB; Kostić DM; Velimirović DV; Petrović PLj; Perisić-Savić MV; KovacevićN S Srp Arh Celok Lek; 1997; 125(1-2):36-44. PubMed ID: 17974353 [TBL] [Abstract][Full Text] [Related]
52. Renal denervation in patients with resistant hypertension: six-month results. Dores H; de Sousa Almeida M; de Araújo Gonçalves P; Branco P; Gaspar A; Sousa H; Canha Gomes A; Andrade MJ; Carvalho MS; Campante Teles R; Raposo L; Mesquita Gabriel H; Pereira Machado F; Mendes M Rev Port Cardiol; 2014 Apr; 33(4):197-204. PubMed ID: 24472425 [TBL] [Abstract][Full Text] [Related]
53. Catheter-based renal denervation for treatment of resistant hypertension. Vase H; Mathiassen ON; Kaltoft A; Pedersen EB; Christensen KL; Buus NH; Lederballe O; Lassen JF; Bøtker HE; Thuesen L Dan Med J; 2012 Jun; 59(6):A4439. PubMed ID: 22677237 [TBL] [Abstract][Full Text] [Related]
54. Renal sympathetic denervation for resistant hypertension. Froeschl M; Hadziomerovic A; Ruzicka M Can J Cardiol; 2013 May; 29(5):636-8. PubMed ID: 23541665 [TBL] [Abstract][Full Text] [Related]
55. The effect of percutaneous renal denervation on muscle sympathetic nerve activity in hypertensive patients. Vink EE; Verloop WL; Siddiqi L; van Schelven LJ; Liam Oey P; Blankestijn PJ Int J Cardiol; 2014 Sep; 176(1):8-12. PubMed ID: 25027168 [TBL] [Abstract][Full Text] [Related]
56. The long-term outcomes of percutaneous therapy for renal artery fibromuscular dysplasia. Davies MG; Saad WE; Peden EK; Mohiuddin IT; Naoum JJ; Lumsden AB J Vasc Surg; 2008 Oct; 48(4):865-71. PubMed ID: 18692345 [TBL] [Abstract][Full Text] [Related]
57. Renal denervation: results of a single-center cohort study. Luetkens JA; Wilhelm K; Düsing R; Woitas RP; Thomas D; Hundt F; Doerner J; Schild HH; Nähle CP Rofo; 2015 Jan; 187(1):36-41. PubMed ID: 25188311 [TBL] [Abstract][Full Text] [Related]
58. Catheter-based renal sympathetic denervation for resistant hypertension: durability of blood pressure reduction out to 24 months. Symplicity HTN-1 Investigators Hypertension; 2011 May; 57(5):911-7. PubMed ID: 21403086 [TBL] [Abstract][Full Text] [Related]
59. An update on renal artery denervation and its clinical impact on hypertensive disease. Bhat A; Kuang YM; Gan GC; Burgess D; Denniss AR Biomed Res Int; 2015; 2015():607079. PubMed ID: 26495305 [TBL] [Abstract][Full Text] [Related]
60. Renal denervation in the management of resistant hypertension: current evidence and perspectives. Jin Y; Persu A; Staessen JA Curr Opin Nephrol Hypertens; 2013 Sep; 22(5):511-8. PubMed ID: 23892701 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]